Real-World Evidence(RWE/RWD)
RWE/RWD Cohort Data Packages
Biomarker-defined patient cohorts with real-world evidence (RWE) and real-world data (RWD). Clinical, treatment, and outcome data ready for regulatory submission, HEOR analysis, and clinical development.
Explore RWE/RWD Cohort Packages
Oncology500
ALK+ NSCLC 1L / Abemaciclib→ALK+ NSCLC 1L / Abiraterone→ALK+ NSCLC 1L / Adagrasib→ALK+ NSCLC 1L / Alectinib→ALK+ NSCLC 1L / Amivantamab→ALK+ NSCLC 1L / Apalutamide→ALK+ NSCLC 1L / Atezolizumab→ALK+ NSCLC 1L / Avapritinib→ALK+ NSCLC 1L / Axitinib→ALK+ NSCLC 1L / Belzutifan→ALK+ NSCLC 1L / Bevacizumab→ALK+ NSCLC 1L / Binimetinib→
Rare Disease200
SMA Presymptomatic / Agalsidase Alfa→SMA Presymptomatic / Agalsidase Beta→SMA Presymptomatic / Alglucosidase Alfa→SMA Presymptomatic / Avalglucosidase Alfa→SMA Presymptomatic / Berotralstat→SMA Presymptomatic / Cannabidiol→SMA Presymptomatic / Casimersen→SMA Presymptomatic / Crizanlizumab→SMA Presymptomatic / Crovalimab→SMA Presymptomatic / Delandistrogene Moxeparvovec→SMA Presymptomatic / Eculizumab→SMA Presymptomatic / Elexacaftor/Tezacaftor/Ivacaftor→
Cardiology150
Atrial Fibrillation NVAF / Aficamten→Atrial Fibrillation NVAF / Alirocumab→Atrial Fibrillation NVAF / Ambrisentan→Atrial Fibrillation NVAF / Apixaban→Atrial Fibrillation NVAF / Bempedoic Acid→Atrial Fibrillation NVAF / Bosentan→Atrial Fibrillation NVAF / Dabigatran→Atrial Fibrillation NVAF / Dapagliflozin→Atrial Fibrillation NVAF / Edoxaban→Atrial Fibrillation NVAF / Empagliflozin→Atrial Fibrillation NVAF / Evinacumab→Atrial Fibrillation NVAF / Evolocumab→
Dermatology50
Acne Vulgaris Moderate-to-Severe / Abrocitinib→Acne Vulgaris Moderate-to-Severe / Dupilumab→Acne Vulgaris Moderate-to-Severe / Lebrikizumab→Acne Vulgaris Moderate-to-Severe / Nemolizumab→Acne Vulgaris Moderate-to-Severe / Tralokinumab→Acne Vulgaris Moderate-to-Severe / Upadacitinib→Atopic Dermatitis Moderate-to-Severe / Abrocitinib→Atopic Dermatitis Moderate-to-Severe / Baricitinib→Atopic Dermatitis Moderate-to-Severe / Dupilumab→Atopic Dermatitis Moderate-to-Severe / Isotretinoin→Atopic Dermatitis Moderate-to-Severe / Lebrikizumab→Atopic Dermatitis Moderate-to-Severe / Nemolizumab→
Endocrinology100
T2DM With CKD / Abaloparatide→T2DM With CKD / CagriSema→T2DM With CKD / Canagliflozin→T2DM With CKD / Dapagliflozin→T2DM With CKD / Denosumab→T2DM With CKD / Dulaglutide→T2DM With CKD / Empagliflozin→T2DM With CKD / Ertugliflozin→T2DM With CKD / Exenatide→T2DM With CKD / Insulin Degludec→T2DM With CKD / Insulin Icodec→T2DM With CKD / Linagliptin→
Gastroenterology100
GERD Erosive / Eluxadoline→GERD Erosive / Lanifibranor→GERD Erosive / Linaclotide→GERD Erosive / Obeticholic Acid→GERD Erosive / Plecanatide→GERD Erosive / Resmetirom→GERD Erosive / Rifaximin→GERD Erosive / Semaglutide (NASH)→GERD Erosive / Survodutide (MASH)→GERD Erosive / Teduglutide→GERD Erosive / Tegoprazan→GERD Erosive / Tenapanor→
Hematology200
Newly Diagnosed AML Fit / Acalabrutinib→Newly Diagnosed AML Fit / Axicabtagene Ciloleucel→Newly Diagnosed AML Fit / Belantamab Mafodotin→Newly Diagnosed AML Fit / Blinatumomab→Newly Diagnosed AML Fit / Bortezomib→Newly Diagnosed AML Fit / Brentuximab Vedotin→Newly Diagnosed AML Fit / Brexucabtagene Autoleucel→Newly Diagnosed AML Fit / Carfilzomib→Newly Diagnosed AML Fit / Ciltacabtagene Autoleucel→Newly Diagnosed AML Fit / Daratumumab→Newly Diagnosed AML Fit / Elranatamab→Newly Diagnosed AML Fit / Enasidenib→
Immunology200
Psoriatic Arthritis Biologic-Naive / Adalimumab→Psoriatic Arthritis Biologic-Naive / Anifrolumab→Psoriatic Arthritis Biologic-Naive / Baricitinib→Psoriatic Arthritis Biologic-Naive / Belimumab→Psoriatic Arthritis Biologic-Naive / Bimekizumab→Psoriatic Arthritis Biologic-Naive / Brodalumab→Psoriatic Arthritis Biologic-Naive / Certolizumab Pegol→Psoriatic Arthritis Biologic-Naive / Deucravacitinib→Psoriatic Arthritis Biologic-Naive / Etanercept→Psoriatic Arthritis Biologic-Naive / Etrasimod→Psoriatic Arthritis Biologic-Naive / Filgotinib→Psoriatic Arthritis Biologic-Naive / Golimumab→
Infectious Disease100
HBV Chronic HBeAg+ / Bictegravir/Emtricitabine/TAF→HBV Chronic HBeAg+ / Cabotegravir + Rilpivirine (LA)→HBV Chronic HBeAg+ / Dolutegravir/Abacavir/Lamivudine→HBV Chronic HBeAg+ / Dolutegravir/Lamivudine→HIV-1 Heavily Treatment-Experienced / Abrysvo (RSV Vaccine)→HIV-1 Heavily Treatment-Experienced / Arexvy (RSV Vaccine)→HIV-1 Heavily Treatment-Experienced / Bezlotoxumab→HIV-1 Heavily Treatment-Experienced / Bictegravir/Emtricitabine/TAF→HIV-1 Heavily Treatment-Experienced / Bulevirtide→HIV-1 Heavily Treatment-Experienced / Cabotegravir (PrEP)→HIV-1 Heavily Treatment-Experienced / Cabotegravir + Rilpivirine (LA)→HIV-1 Heavily Treatment-Experienced / Cefiderocol→
Nephrology50
CKD with Anemia / Atrasentan→CKD with Anemia / Dapagliflozin→CKD with Anemia / Daprodustat→CKD with Anemia / Empagliflozin→CKD with Anemia / Felzartamab→CKD with Anemia / Finerenone→CKD with Anemia / Iptacopan→CKD with Anemia / Patiromer→CKD with Anemia / Roxadustat→CKD with Anemia / Sodium Zirconium Cyclosilicate→CKD with Anemia / Sparsentan→CKD with Anemia / Tolvaptan→
Neurology150
Early Alzheimer's Disease / Aducanumab→Early Alzheimer's Disease / Atogepant→Early Alzheimer's Disease / Brivaracetam→Early Alzheimer's Disease / Cenobamate→Early Alzheimer's Disease / Deutetrabenazine→Early Alzheimer's Disease / Donanemab→Early Alzheimer's Disease / Duloxetine→Early Alzheimer's Disease / Edaravone→Early Alzheimer's Disease / Eptinezumab→Early Alzheimer's Disease / Erenumab→Early Alzheimer's Disease / Fremanezumab→Early Alzheimer's Disease / Galcanezumab→
Ophthalmology50
DME Treatment-Naive / Aflibercept 8mg→DME Treatment-Naive / Avacincaptad Pegol→DME Treatment-Naive / Brolucizumab→DME Treatment-Naive / Cyclosporine Ophthalmic→DME Treatment-Naive / Faricimab→DME Treatment-Naive / Ixoberogene Soroparvovec→DME Treatment-Naive / Latanoprost→DME Treatment-Naive / Lifitegrast→DME Treatment-Naive / Netarsudil→DME Treatment-Naive / Pegcetacoplan→DME Treatment-Naive / Ranibizumab→Wet AMD / Aflibercept 8mg→
Respiratory100
COPD Eosinophilic / Astegolimab→COPD Eosinophilic / Benralizumab→COPD Eosinophilic / Brensocatib→COPD Eosinophilic / Depemokimab→COPD Eosinophilic / Dupilumab→COPD Eosinophilic / Ensifentrine→COPD Eosinophilic / Gefapixant→COPD Eosinophilic / Itepekimab→COPD Eosinophilic / Mepolizumab→COPD Eosinophilic / Nerandomilast→COPD Eosinophilic / Nintedanib→COPD Eosinophilic / Omalizumab→
Why Persly RWE/RWD
Fast Evidence Framing
From cohort definition to data delivery in weeks, not months.
Publication-Backed Quality
Every dataset meets regulatory-grade standards with full audit trail.
AI-Powered Enrichment
Medical AI enriches raw data with biomarker annotations, endpoint extraction, and cohort matching.
Featured RWE/RWD Cohort Packages
Biomarker-defined patient cohorts with real-world evidence (RWE) and real-world data (RWD). Clinical, treatment, and outcome data ready for regulatory submission, HEOR analysis, and clinical development.